HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The International Collaborative Study on maternal phenylketonuria: organization, study design and description of the sample.

Abstract
The International Maternal Phenylketonuria (PKU) Collaborative Study commenced in 1984 to evaluate the efficacy of the low-phenylalanine diet in reducing the morbidity associated with maternal PKU syndrome. Four hundred and sixty eight (468) pregnancies resulted in 331 live births, 3 stillbirths, 61 spontaneous abortions, 2 ectopic pregnancies and 71 elective terminations. Since its inception, the study has steadily progressed toward its goal of diet initiation preconception or early in pregnancy. By 1994, 51% of the sample began the diet preconceptionally, with an additional 41% doing so by 8 weeks gestation. The number of adolescent pregnancies has decreased from 31% to 9%, college attendance has increased from 5% to 16%, number of women in the lowest socioeconomic classes has decreased from 95% to 59% and average IQ has increased from 78 to 88. The organization of the network of 130 referral centers and clinics within the U.S.A., Canada and Germany and the objectives of the scientific research investigation have served to provide a derived benefit of outreach, education, reproductive counseling and early diet intervention in a large cohort of PKU women.
AuthorsE G Friedman, R Koch, C Azen, H Levy, W Hanley, R Matalon, B Rouse, F Trefz, F de la Cruz
JournalEuropean journal of pediatrics (Eur J Pediatr) Vol. 155 Suppl 1 Pg. S158-61 (Jul 1996) ISSN: 0340-6199 [Print] Germany
PMID8828635 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Topics
  • Adolescent
  • Adult
  • Diet, Protein-Restricted
  • Female
  • Humans
  • Multicenter Studies as Topic
  • Phenylketonuria, Maternal (diet therapy)
  • Pregnancy
  • Pregnancy Outcome
  • Research Design
  • Socioeconomic Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: